#Endometrial Ablation Market Industry

[marketsresearchinsights]

Endometrial Ablation Devices Market Opportunities, Top Regions, Growth and Forecast by 2031

The Insight Partners latest market research - " Endometrial Ablation Devices Market Forecast | Share and Size - 2031", provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, Endometrial Ablation Devices market size & estimations, competitive landscape, and changing market trends.

The Endometrial Ablation Devices market report represents a detailed overview of the current market situation and forecasts till the 2031. The study is perhaps a perfect mix of qualitative and quantitative information highlighting key market developments, challenges, and competition the industry faces alongside gap analysis and new opportunities available and Endometrial Ablation Devices market trends. This report offers market size, recent trends, growth, share, development status, government policy, market dynamics, cost structure, and competitive landscape. The research report also includes the Endometrial Ablation Devices market growth potential in the given period of forecast.

This research is based on valid information sources that make it a credible asset. Through a range of quantitative methods and qualitative approaches, this research brings forward comprehensive insights on trends, drivers, and restrictions ahead of Endometrial Ablation Devices market players. PESTEL, Porter's five forces, and SWOT models are used for Endometrial Ablation Devices market analysis of the business environment across a range of categories, geographical regions, and applications.

Key companies in the Endometrial Ablation Devices market are- , AEGEA Medical, Inc., Boston Scientific Corporation, CooperSurgical Inc., Ethicon US, Hologic, Inc., Idoman Teoranta, Medtronic Plc, Minerva Surgical, Inc, Olympus Corporation, Omnitech Systems, Inc. and others

Market Analysis and Insights:

The report identifies emerging revenue pockets and opportunities for growth in the market. It analyses changes in market regulations and provides a strategic growth analysis, which can be used by businesses to develop effective growth strategies.

Overall, this report is an essential resource for businesses seeking to stay ahead of the competition in the Endometrial Ablation Devices market. With its comprehensive Endometrial Ablation Devices market analysis of recent developments and emerging trends, it provides valuable insights into the market that can be used to develop effective growth strategies and improve market positioning.

Market Drivers and Restraints:

The report provides valuable information on the production costs, supply chain dynamics, and raw materials that are essential to the Endometrial Ablation Devices market. The report identifies key market restraints, such as economic constraints in emerging countries and business market obstacles. By understanding these risks and challenges, businesses can develop strategies to mitigate them and achieve long-term success in this exciting and dynamic industry to increase their Endometrial Ablation Devices market share.

Market Segmentation:

The political and economic landscape of the Endometrial Ablation Devices market is analyzed in depth, providing a comprehensive understanding of the market's potential risks and opportunities. The report includes a detailed analysis of the competitive landscape of the market, identifying the top players and their Endometrial Ablation Devices market size, and evaluating their strategies and performance. The research report covers a wide range of topics, including market trends, technological advancements, and emerging opportunities, providing valuable insights for businesses looking to expand their presence in the market.On the Basis of Device Type this market is categorized further into-

Hysteroscopy devices

Thermal balloon ablators

Radiofrequency endometrial ablation devices

Hydrothermal ablators

Electrical ablators

Cryoablation devices

Microwave endometrial ablators

Others

On the Basis of End User this market is categorized further into-

Ambulatory Surgery Center

Clinic

Hospital

On the Basis of Geography this market is categorized further into-

North America

Europe

Asia Pacific

and South and Central America

Key regions Endometrial Ablation Devices Market Research Report:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

[healthcaremarketfmi]

Ablation Devices Market Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2033

The global ablation devices market is anticipated to reach US$ 4.4 Billion in 2023. The market could grow at a promising CAGR of 11.1%, attaining a market valuation of US$ 12.6 Billion by 2033.

Key Factors Aiding the Growth of the Ablation Devices Market Between 2023 and 2033:

Wide adoption of minimally invasive surgical processes, owing to lesser patient trauma and recovery time

Wide utility in oncology, as incidences of cancer rise globally

Increasing consumer demand for radio-frequency-based ablation devices during the forecast period

Recent technological innovations such as heat-based ablation devices are aiding in consumer base expansion as well as application

Get Sample Report + Related Graphs & Charts @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11254

 Ablation Devices Offer Advantages Over Traditional Surgical Procedures

Ablation devices offer minimally invasive procedures, which are less painful than traditional surgical procedures. Hence the recovery time is also shorter. The damage incurred to the surrounding tissues shall also be minimal. This has bolstered consumer preference for the product.

Expansion of Product Application Warrants Key Innovations

The application of ablation Devices for large and bulky tissues isn’t possible currently. This includes sensitive areas such as the bone and neck nodules. Ablation treatment is yet to garner wide availability in remote locations. Hence, many patients belonging to low-income groups could have restricted access to ablation treatments.

Hence, key players must consistently work on developing alternatives that are more efficient with diverse applications. By making these new variants more affordable and easily accessible, key players can attract a larger consumer base. The heavy investments being channeled by key players into research and development could be beneficial for overcoming such market restraints, in the foreseeable future.

Ask Analyst for Report Customization and Explore TOC & List of Figures @ https://www.futuremarketinsights.com/ask-question/rep-gb-11254

Key Takeaways from the Report :

Between 2017 and 2022, the market recorded a CAGR of 9.8%, attaining a valuation of US$ 4.9 billion in 2022.

During the forecast period, the United States market is expected to grow at a CAGR of 11.0%, to reach a valuation of US$ 4.0 billion by 2033.

The United Kingdom market is projected to grow at a CAGR of 12.6% between 2023 and 2033.

The top segment by product type, the advanced ablation catheters, is expected to grow at a CAGR of 10.7%.

By technology, the radiofrequency segment dominates the market and is anticipated to grow at a CAGR of 10.1%.

Key Market Developments:

In February 2022, Ra Medical Systems secured the patent for its latest innovation: a support catheter. The product can easily be combined with any small flexible liquid core catheter, facilitating laser ablation.

In November 2021, Hologic, Inc., launched the NovaSure V5 Global Endometrial Ablation (GEA). This latest innovation is crafted with EndoForm technology. The product can accommodate different types of anatomical variability and cervical canals.

In August 2019, Boston Scientific Corporation launched its advanced cryoablation system which is known as ICEfx™. The specialty of this device is that it is a more compact, portable alternative to older versions.

Key Players:

Boston Scientific Corporation

Medtronic plc

Abbott Laboratories

Johnson and Johnson

AngioDynamics Inc.

Biotronik SE & Co. KG.

Japan Lifeline Co.

CathRx Ltd.

AtriCure, Inc.

[megharesearch]

The Uterine Fibroids Treatment market research report discusses the importance of the segments as well as the regional markets. An accurate overview of different segments and regions has been prepared on the basis of the market size as well as the growth rate (CAGR). Different industry professionals and research analysts in various regions have examined and validated the data presented in this research report.

[neha24blog]

Endometrial Ablation Market Size Is Poised To Reach USD 5.4 Billion By 2028: Grand View Research Inc.

Endometrial Ablation Market Size Is Poised To Reach USD 5.4 Billion By 2028: Grand View Research Inc.

San Francisco, 13 Oct 2021: The Report Endometrial Ablation Market Size, Share & Trends Analysis Report By Type (Procedures, Devices), By End Use (Hospital, ASC), By Region (Asia Pacific, Europe, North America), And Segment Forecasts, 2021 – 2028 The global endometrial ablation market size is expected to reach USD 5.4 billion by 2028, registering a CAGR of 5.2% over the forecast period,…

[researchinhealthcare]

Dysfunctional Uterine Bleeding Market By 2027 | Global Industry Analysis and Trends, Healthcare Products, Personal Care Products, Distribution Channel

Dysfunctional Uterine Bleeding Market Overview :

According to the American Society for Reproductive Medicine, dysfunctional uterine bleeding is most common during puberty and menopause. It can also can occur at any time in women due to hormonal imbalance.

 Polycystic ovary syndrome (PCOS), endometriosis, uterine polyps, uterine fibroids, Sexually Transmitted Diseases (STDS) are common causes of dysfunctional uterine bleeding. It can be diagnosed by performing an endometrial biopsy or blood tests.

The rising prevalence of uterine disorders such as endometrial cancer among women, availability of reliable diagnostic tests, and overall demand for new treatment for uterine bleeding drive the market growth.  Increasing number of awareness drives and campaigns regarding cancer among women further influence the market growth.

The global dysfunctional uterine bleeding market is expected to grow at a CAGR of 8.2% during the forecast period.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Dysfunctional uterine bleeding market research report–Global forecast till 2023.”

Dysfunctional Uterine Bleeding Market Regional Analysis :

America is the largest market for dysfunctional uterine bleeding market owing to the rising prevalence of uterine cancer and other uterine disorders among women. According to the American Cancer Institute, about 61,380 new cases of uterine cancer will be diagnosed in 2017 and 8% of the urine cancers are sarcomas.

Europe is the second largest market owing to an increasing demand for diagnosis and treatment measures for uterine cancer, fibroids and other disorder, and increasing emphasis on women healthcare. Additionally, availability of funds for research and development activities accelerates the market growth in the European countries.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing prevalence of menstrual disorders, and sexually transmitted diseases (STI) among women in developing nations. Furthermore, increasing awareness about STI and preventive measures to be taken also influences the market growth.

The Middle East & Africa also show a steady rise in the market owing to increasing focus on women and child health, and need of primary care services in developing regions.

Free Analysis Report Sample @ https://www.marketresearchfuture.com/sample_request/4685

Dysfunctional Uterine Bleeding Market Segmentation :

The global dysfunctional uterine bleeding market is segmented on the basis of type, diagnosis, treatment, and end user.

On the basis of type, market is segmented into ovulatory, and anovulatory.

On the basis of diagnosis, the market is segmented into hysteroscopy, ultrasonography, dilation and curettage, endometrial biopsy, and others.

On the basis of treatment, the market is segmented into pharmacologic treatment, hysterectomy, endometrial ablation, and others. The pharmacologic treatment includes oral contraceptives, estrogen, progestins, desmopressin and others.

On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, pharmaceutical companies, and others.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/dysfunctional-uterine-bleeding-market-4685

Dysfunctional Uterine Bleeding Market Major Players :

Some of the key players in the global market are B. Braun Melsungen AG (Germany), Hologic Inc. (U.S.), Karl Storz Gmbh & Co. KG (Germany), Medgyn Products, Inc., Olympus (Japan), Richard Wolf GmbH (Germany), Stryker (U.S.), Xion Medical GmbH (Germany), Cadila Pharmaceuticals Ltd. (India), Torrent Phamraceuticals (India).

[healthcare-market]

Gynecological Devices Market Insights Shared in Detailed Report

Transparency Market Research (TMR) has published a new report titled, ‘Gynecological Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Gynecological Devices market was valued at US$ 17,449.09 Mn in 2018 and is projected to expand at a CAGR of 3.8 % from 2019 to 2027.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=613

Overview

· Gynecological devices are the instruments and equipment used in the treatment of the gynecological disorders. Gynecological devices includes surgical devices, hand instruments, diagnostics imaging services and gynecological chairs.

· The rise in demand of the gynecological devices are ascribed to technological advancements leading to the advanced products, rising incidences of gynecological procedures, increase in C-section procedure, uterine fibroids and others conditions.

· Rise in the adoption of the disposable equipment due to increasing need of sanitization, sterilization, rise in cases of emergency visits at trauma centers are estimated to propel the market of the gynecological devices market in coming years.

Technological advancements in gynecological devices to Drive Market

· Minimally invasive therapy is a highly dynamic area of innovation. Minimally invasive therapy may prevent the need for major open-surgery procedures. In terms of health outcomes, it offers the following benefits: no need for general anesthesia, absence of sequelae of open surgery procedures, smaller scars, shorter hospital stay or outpatient treatment, and faster return to normal life.

· Two advanced approaches to minimally invasive surgery presented recently are the da Vinci robotic platform and single port laparoscopic surgery (SPLS). Robotic surgery has many advantages, such as, 3-dimensional view, ergonomically comfortable position for the surgeon, and wrist-like motion of the robotic arm. Presently, robotic technology is widely used in gynecology surgeries, such as, hysterectomy, sacrocolpopexy, myomectomy, etc.

· Single port laparoscopic surgery has numerous possible advantages including, reduced postoperative pain, fewer operative complications, and improved results compared to conventional laparoscopy

Request for Analysis of COVID19 Impact on Gynecological Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=613

Surgical Devices Segment to Dominate Market

· Based on product, the global gynecological devices market has been divided into surgical devices, Hand Instruments, Diagnostic Imaging systems, and gynecological chairs The surgical device segment has been bifurcated into Endoscopy Devices, Endometrial Ablation Devices, Fluid Management Systems, and Female Sterilization And Contraceptive Devices.

· The surgical device segment dominated the global gynecological devices market in 2018 and the trend is projected to continue during the forecast period. Increase in demand for minimally invasive procedures and technological advancements for growing gynecological procedures are few factors likely to drive the segment during the forecast period.

· Moreover, shift in trend from invasive to minimal invasive surgery is likely to boost the segment growth in forecast period. Moreover, increase in the cesarean surgical procedure is also likely to propel the market of the gynecological devices market across globe.

Request a Sample of Gynecological Devices Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=613

North America to Dominate Global Market

· In terms of region, the global gynecological devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global gynecological devices market in 2018, followed by Europe.

· North America accounted for major share of the global gynecological devices market in 2018, owing to technological advancements, growing awareness about minimally invasive treatments for gynecological procedures, aging of the baby boomer population, better reimbursement policies, better reimbursement policies, advancements in healthcare and high health care awareness among the population of the U.S. are the major drivers of the Gynecology Devices market in North America.

·  The Gynecological Devices market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to large patient base in countries such as India and China, rise in awareness, and developing health care infrastructure. As per expertise, China is expected to be highly attractive market attributable to huge gynecological diseases affected patient pool with high unmet needs and developing healthcare infrastructure.

Buy now Gynecological Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=613&ltype=S

Competitive Landscape

The global Gynecological Devices market is fragmented in terms of number of players. Key players in the global market include Boston Scientific Corporation, Medtronic plc, Johnson & Johnson Services (Ethicon, Inc.), Stryker Corporation, Merck & Co, Inc., Olympus Corporation, Cooper Surgical, Inc., Hologic, Inc., Richard Wolf Gmbh, Karl Storz Gmbh & Co. KG, and other players.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

Contact

Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com

[pharmaceuticalhealthcareana-blog]

Endometrial Ablation Market - Global Industry Insights, and Opportunity Analysis, 2025

Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and type of patient under treatment, different endometrial ablation methods are present which includes such as Radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, microwave ablation techniques.

According to the Centers for Disease Control and Prevention (CDC), 10 million American women are affected with heavy bleeding (menorrhagia) each year. The likely cause of abnormal bleeding includes hormonal imbalance disturbance in post menopause, fibroids or polyps in uterus, birth control pills, endometrium cancer and use of intrauterine device (IUD).

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1109

[aartichede08]

Hysteroscopy Instruments Market Research, Industry Outlook, Size, Growth Factors, And Forecast 2028

Hysteroscopy is used to investigate abnormal vaginal bleeding, such as bleeding after the menopause, heavy periods, and bleeding between periods. It is also used when abnormalities of the uterus are found during an ultrasound scan. These include thickening of the lining of the uterus known as the endometrium, polyps and fibroids. Hysteroscopy may also be advised when the uterus appears to have an abnormal shape. Hysteroscopy enables the inside of the uterus, known as the endometrial cavity, to be seen and appropriate treatment to be carried out under direct vision.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/hc2072-hysteroscopy-instruments-market-report

HYSTEROSCOPY INSTRUMENTS MARKET OUTLOOK

Growing female geriatric population and increasing number of gynaecological diseases are boosting hysteroscopy instruments market globally. Moreover, increasing adoption of minimally invasive treatments and office hysteroscopy procedures are significantly contributing towards the growth of the market. Hysteroscopic polypectomy, myomectomy, and endometrial ablation are just a few of the commonly performed procedures worldwide. However, availability of alternative options for diagnosis and treatment of gynaecological conditions is hampering the market growth.

HYSTEROSCOPY INSTRUMENTS MARKET SEGMENTAL OVERVIEW

The report analyses the global hysteroscopy instruments market based on product, application, end user and geography.

HYSTEROSCOPY INSTRUMENTS MARKET BY PRODUCT

The hysteroscopy instruments market is categorized into various products such as hand-held instruments including dilators, scissors and other hand-held instruments; hysteroscopes including flexible hysteroscopes and rigid hysteroscopes; resectoscopes such as, bipolar resectoscopes and unipolar resectoscopes; hysterosheaths; fluid management systems and hysteroscopic tissue removal systems.

HYSTEROSCOPY INSTRUMENTS MARKET BY APPLICATION

Various applications of the hysteroscopy instruments market comprise of diagnostic hysteroscopy, endometrial ablation, myomectomy, operative hysteroscopy, polypectomy and tubal sterilization. Myomectomy, sometimes also fibroidectomy, refers to the surgical removal of uterine leiomyomas, also known as fibroids. In contrast to a hysterectomy, in the myomectomy procedure, the uterus remains preserved and the woman can retains her reproductive potential.

HYSTEROSCOPY INSTRUMENTS MARKET BY END USER

The end user of this market are hospitals, ambulatory surgery centers (ASCs) and clinics. Overall, patients prefer less invasive outpatient procedures that can be performed in doctor’s office, instead of hospital procedures that would potentially require general anaesthesia. Minimally invasive laser treatments for hysteroscopy are capitalizing on this trend and represent the fastest-growing market worldwide.

HYSTEROSCOPY INSTRUMENTS MARKET BY GEOGRAPHY

By geography, the global hysteroscopy instruments market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. In 2018, North America dominated the market owing to factors such as technological innovations, increasing healthcare spending, and swelling government initiatives to create awareness regarding women’s health. Moreover, Asia-Pacific hysteroscopy instruments market is expected to grow at the fastest CAGR due to rising government initiatives for the modernization of healthcare infrastructure, large population base and growing incidence of gynaecological diseases.

HYSTEROSCOPY INSTRUMENTS MARKET KEY PLAYERS

The leading market players of the global hysteroscopy instruments market are B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Coopersurgical, Inc. (Cooper Companies, Inc.), Ethicon, Inc. (Johnson & Johnson), Hologic, Inc., Hospiline Equipments Pvt. Ltd, Karl Storz GmbH & Co. Kg, Maxer Medizintechnik GmbH, Medgyn Products, Inc., Medicon EG, Medtronic PLC., Olympus Corporation, Richard Wolf GmbH and Stryker Corporation.

Buy now Hysteroscopy Instruments Market Report https://www.axiommrc.com/buy_now/hc2072-hysteroscopy-instruments-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

[crifax123]

U.S. Uterine Fibroid Market to be Propelled by High Occurrences of Uterine Fibroids, Options for Pharmacologic Therapies to Treat Symptoms, and Considerable Awareness by CAGR of ~4% During 2023 – 2033

Kenneth Research published a report titled “U.S. Uterine Fibroid Market: Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the U.S. uterine fibroid market in terms of market segmentation by procedure type and by the end user.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The U.S. uterine fibroid market is expected to hold a revenue of ~ USD 299 million by 2033 growing from ~ USD 299 million in 2022. The market growth can be attributed to the wide occurrence of uterine fibroids among the women in the United States (U.S.), the availability of medications to treat symptoms, the awareness about the health condition, and the investments made into the development of medical devices.

The U.S. uterine fibroid market is expected to grow at a CAGR of approximately 4% from 2023-2033. The market is segmented by product type into endometrial ablation, MRI guided procedures, hysterectomy, myomectomy, uterine artery embolization, radiofrequency ablation, and others. Of these, the hysterectomy segment is anticipated to hold the largest market share by the end of 2033, owing to the ubiquity of the surgical method in the treatment of uterine fibroids all over the world.

Large Presence of Women Suffering from Uterine Fibroids to Boost the Market Growth

It is estimated that more than 25 million of women between 15 and 50 in the U.S. suffer from the occurrence of uterine fibroids. A majority of these women were found to be suffering from symptoms, including pain, heavy menses, anemia, increased urinary frequency, and reproductive issues.

Women Seeking Pharmacologic Therapies to Treat Symptoms to Boost the Market Growth

It was observed that more than 70% of the women with a diagnosis of uterine fibroid had sought pharmacologic therapy, including over-the-counter pain relief, iron supplements, prescription treatments, and hormonal contraceptives, to treat and alleviate the symptoms. The easy availability of these medications effective in shrinking fibroids, lessening menstrual bleeding, and in improving anemia is thought to boost the market growth.

However, the majority of the treatment methods involving surgeries, the unsupportive medical insurance policies and the high cost involved in the treatment of uterine fibroids are expected to operate as key restraints to the growth of the U.S. uterine fibroid market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the U.S. uterine fibroid market which includes company profiling of BLUE ENDO, Boston Scientific Corporation (BSC), CooperSurgical, Inc., KARL STORZ SE & Co. KG, Myovant Sciences GmbH., LiNA Medical ApS, Merit Medical Systems, Olympus Corporation of the Americas, Richard Wolf GmbH, Medtronic, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the U.S. uterine fibroid market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Request Report Sample : https://www.kennethresearch.com/sample-request-10042790

Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: sales@kennethresearch.com

U.S. Phone: +1 313 462 0609

[researchvishal]

Ablation Devices Market Share On Major Suppliers, Business Standards, And Technology Trends In-Depth

The ablation devices market growth is expected to reach US$ 3.9 billion in 2022. By 2029, the market is anticipated to grow at a strong 11.3% CAGR and reach US$ 8.3 billion. Here are a few elements that should help to continued growth within the given projection period.

Key Takeaways of Ablation Devices Market Study

Advanced ablation catheters has emerged as the largest segment by product type, representing 68% of overall revenue of the ablation devices market in 2021. This is attributed to being a viable alternative management strategy and their frequent use in the clinical management of paroxysmal atrial fibrillation. Further, better clinical outcomes through new ablation technologies to treat most arrhythmias and certain types of structural heart disease are responsible for their significant market share.

Hospitals accounted for a leading revenue share of 52%, owing to the availability of ablation devices and skilled personnel for better clinical management of various diseases across several medical domains.

Radiofrequency captured a major value share in the technology segment, attributable to its lesser potential risk and side effects, lesser recovery time, and its effective application on patients suffering from multiple tumors.

By functionality, automated or robotic ablation devices are expected to grow at an impressive rate; these accounted for around one-third of the global ablation devices market in 2021.

Cumulatively, North America and Europe hold a major share of the global ablation devices market, with the former holding a noteworthy share, and is expected to progress at a high CAGR during the forecast period.

Increasing prevalence of chronic diseases, high purchasing power, technology advancements, and government support for quality healthcare are contributing to the hegemony of North America in the ablation devices market, in terms of value.

Ablation devices are gathering momentum around the world, owing to their proven procedural efficacy, improved safety profiles, and awareness in current asymptomatic procedure-related events. Over the last decade, ablation devices market have undergone significant technical improvements. These devices offer the benefits of enhanced patient quality of life, patient safety, and clinician efficiency, and are used as a frontline therapy.

Decrement in long-term hospitalization and minimal invasion are critical factors that are expected to propel the growth of the ablation devices market over the coming years. Ablation devices have gained clinical significance on the basis of effective treatment across various medical applications, as well as due to shorter recovery time with affordable minimal invasive procedures. Moreover, rising prevalence of chronic diseases such as cardiovascular diseases and tumors are expected to provide impetus to market growth.

However, the coronavirus (COVID-19) pandemic has put forward a challenging situation for players in the ablation devices market. The pace at which the pandemic is spreading and the resultant humanitarian toll is making it difficult for market players to react accordingly. As the healthcare industry is addressing the pandemic along with patients’ ever-evolving expectations, market players are devising future-ready strategies to brace themselves for the humanitarian and economic concerns ahead.

The global ablation devices market was valued at US$ 2.7 Bn in 2021, and is anticipated to witness a CAGR of 11% during the forecast period (2022–2029).

Ablation Devices Manufacturers to Focus on New Product Launches

Continuous upgradation and product launches in the ablation devices market are spurring intense competition among market players. Several companies are focusing on new product approvals for ablation devices. For example, in February 2020, Hologic, Inc. launched a next-generation NovaSure ADVANCED global endometrial ablation (GEA) system in the U.S. This system has been approved by the Food and Drug Administration (FDA). Regional and local players are also implementing these differentiating strategies to sustain their competitiveness.

Ablation Devices Market by Category

By Product Type:

Bipolar Energy Ablation Devices

Cryotherapy Ablation Devices

Hydrothermal Ablation (HTA) Devices

Thermal Balloon Ablation Devices

Advanced Ablation Catheters

Cryoablation Catheters

Irrigated tip RF Ablation Catheters

Laser Ablation Catheters

Standard Ablation Catheters

Conventional Radiofrequency Ablation Catheters

MRI Guided Neurosurgical Ablation

MRI Guided Laser Therapy Systems

MRI Guided RF Ablation Systems

MRI Guided Focused Ultrasound Systems

Accessories

By Technology:

Laser

Radiofrequency

Microwave

Ultrasound

Others

By Application:

Cardiovascular

Cancer

Urological

Ophthalmic

Others

By Functional:

Automated Robotics

Conventional

By End User:

Hospitals

Ambulatory Surgical Centers

Clinics

[dbmrmarketnews]

North America ablation devices market is expected to witness market growth at a rate of 10.55% in the forecast period of 2022 to 2029, and is estimated to reach the value of USD 4.18 billion by 2028.

[healthcaredbmrnews]

North America ablation devices market is expected to witness market growth at a rate of 10.55% in the forecast period of 2022 to 2029, and is estimated to reach the value of USD 4.18 billion by 2028.

[neha24blog]

There is an increasing demand for endometrial ablation procedures as well as devices owing to the rising prevalence of gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, and growing public awareness about endometrial ablation.